Clinical Trial Update: A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT [Phase 3]

View source ↗

Summary

Phase 3 study evaluating ATG-F for engraftment, graft-versus-host disease, and graft-versus-leukemia effects in haplo-identical stem cell transplantation; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• ATG-F (anti-thymocyte globulin fragment F)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Allogeneic Haplo-Stem Cell Transplatation (SCT), Graft Versus Host Disease | Phase 3 | Status: TERMINATED